ZENDAL
MTBVAC
Vaccines
Cancer
MTBVAC vaccine is based on a genetically attenuated strain of a clinical isolate of M. tuberculosis manufactured by BIOFABRI (Zendal Corp.). MTBVAC is in Phase 3 in newborn infants in South Africa, Senegal and Madagascar and finished Phase2a in adults
3Phase III,
2Phase II,
1Phase I,
2Regulatory Preclinical,
1Non Regulatory Preclinical